|
Summary Information: Tempest Therapeutics Inc. Common Stock NASDAQ:TPST |
  admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Millendo Therapeutics is a clinical-stage biopharmaceutical company primarily focused on developing novel treatments for endocrine diseases where current therapies do not exist or are insufficient. Millendo seeks to create distinct and transformative treatments where there is a significant unmet medical need.
__The following are links to various summary and news pages for __Tempest Therapeutics Inc. Common Stock [ TPST ]. __Note: Some Links might not have information for the company. |
|